About St. Elisabeth-Krankenhaus, Senologie/Brustzentrum
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at St. Elisabeth-Krankenhaus, Senologie/Brustzentrum
During the past decade, St. Elisabeth-Krankenhaus, Senologie/Brustzentrum conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
2016-02-24
2019-07-01
Terminated
732
Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis
2015-11-17
2018-01-18
Completed
160
MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
2017-12-13
2018-05-22
Completed
33
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
2018-11-19
2022-06-08
Terminated
146
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at St. Elisabeth-Krankenhaus, Senologie/Brustzentrum
According to Clinical.Site data, the most researched conditions in "St. Elisabeth-Krankenhaus, Senologie/Brustzentrum" are
"Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials) and "Triple-negative Breast Cancer" (1 trials). Many other conditions were trialed in "St. Elisabeth-Krankenhaus, Senologie/Brustzentrum" in a lesser frequency.
Clinical Trials Intervention Types at St. Elisabeth-Krankenhaus, Senologie/Brustzentrum
Most popular intervention types in "St. Elisabeth-Krankenhaus, Senologie/Brustzentrum" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials), "Cyclophosphamide" (1 trials), "Doxorubicin" (1 trials), "Filgrastim" (1 trials) and "Giredestrant" (1 trials). Other intervention names were less common.
Clinical Trials Genders at St. Elisabeth-Krankenhaus, Senologie/Brustzentrum
The vast majority of trials in "St. Elisabeth-Krankenhaus, Senologie/Brustzentrum" are
2 trials for "All" genders.
Clinical Trials Status at St. Elisabeth-Krankenhaus, Senologie/Brustzentrum
Currently, there are NaN active trials in "St. Elisabeth-Krankenhaus, Senologie/Brustzentrum".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in St. Elisabeth-Krankenhaus, Senologie/Brustzentrum,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in St. Elisabeth-Krankenhaus, Senologie/Brustzentrum, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".